Dr. John Leonard Discusses Emerging Treatment Options for Follicular Lymphoma

Recently, Lymphoma Program Director, Dr. John Leonard was interviewed by OncLive on the potential use of new therapies including lenalidomide, idelalisib, and ibrutinib in the treatment of follicular lymphoma. As Dr. Leonard noted,

“When patients relapse after initial therapy, the key factors in choosing a treatment include the time from first therapy, the time to reoccurrence, how sick they are, their age, and what they need in terms of symptom relief at that time…” 

The full interview can be read here.

A list of available clinical trials for follicular lymphoma available at Weill Cornell Medicine can be found in our clinical trials listing.

Author: lymphomaprogram

Located on the Upper East Side of New York City, the Lymphoma Program at Weill Cornell Medical College/NewYork Presbyterian Hospital is internationally recognized for our efforts to enable patients with non-Hodgkin lymphoma, Hodgkin disease and related disorders to have the best possible clinical outcome, including cure when possible.

Post a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: